AGL.LLSEHealthcare · Medical - Diagnostics & Research

ANGLE plc

$0.92-5.64%($-0.06)

TickerSpark Score

43/100

Weak

Valuation

Profitability

100

Growth

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AGL.L research report →

52-Week Range0% of range

Low $0.85

Current $0.92

High $17.45

Companyangleplc.com

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD multiplex analysis system for routine and focused multiplex analysis of DNA, RNA or protein biomarkers. The company was founded in 1994 and is based in Guildford, the United Kingdom.

CEO: Andrew David William Newland ACA, Meng
IPO: 2004
Employees: 150
HQ: Guildford, GB

Price Chart

-86.50% · this period

Growth & Income

Revenue: $2.86M · 30.92%
Net Income: $-14,225,000 · 29.34%
EPS: $-0.05 · 37.65%
Op Income: $-15,096,000
FCF YoY: 8.11%

Performance & Tape

52W High: $17.45
52W Low: $0.85
50D MA: $3.88
200D MA: $7.72
Beta: 0.08
Avg Volume: 5.63M

Get TickerSpark's AI analysis on AGL.L

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime